OGEN
Oragenics Inc.
stockNYSEAMERICAN
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.47 | 2026-09-28 | +7.06% | -0.937 |
| 1M | 0.51 | 2026-09-04 | -1.00% | 2.336 |
| 3M | 0.58 | 2026-07-06 | -12.95% | 1.242 |
| 6M | 0.58 | 2026-04-06 | -13.65% | 0.976 |
| 1Y | 1.30 | 2025-10-06 | -61.16% | 1.479 |
| 2Y | 12.60 | 2024-10-04 | -95.99% | — |
| 5Y | 1,079.64 | 2021-10-05 | -99.95% | 0.945 |
Oragenics Inc. (NYSEAMERICAN:OGEN) stock price today is $0.50, and today's volume is 22,424. OGEN is up 3.559% today. The 30 day average volume is 31,700. OGEN market cap is $2.28M with 4.51M shares outstanding.